Potential uses of polyamine biosynthesis inhibitors in tumor therapy.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage; D002453:Cell Cycle / Q000187:drug effects; D004260:DNA Repair / Q000187:drug effects; D004359:Drug Therapy, Combination; D000518:Eflornithine; D006801:Humans; D008935:Mitoguazone / Q000494:pharmacology / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy*; D009952:Ornithine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D065108:Ornithine Decarboxylase Inhibitors; D011073:Polyamines / Q000037:antagonists & inhibitors*; D012854:Sister Chromatid Exchange / Q000187:drug effects
D000970:Antineoplastic Agents; D065108:Ornithine Decarboxylase Inhibitors; D011073:Polyamines; C025025:alpha-methylornithine; D009952:Ornithine; D008935:Mitoguazone; D000518:Eflornithine